ESR1 and inflammatory breast carcinoma: ER status was also an important prognostic factor for OS and DSS for patients with IBC; patients with ER-negative tumors had worse OS (p = 0.0077) and DSS (p = 0.01) relative to patients with ER-positive IBC tumors (Figure 3a,b).